CEACAM5 and neoplasm: Conventional assays including traditional tumor biomarkers (e.g. carbohydrate antigen 19‐9 [CA 19‐9], carcinoembryonic antigen [CEA], and carbohydrate antigen 125 [CA‐125]) are readily available in clinical settings.